ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

6 links0 made here, not in the record11 judgments2 judges (the rules as one: Rule based)0 record changes seen
Model not recordedRule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05404945Fitness-adapted,Pembrolizumab-based Therapyfor Untreated ClassicalHodgkin Lymphoma Patients60 Years of Age and AboveUniversity of VirginiaPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSHodgkin DiseaseNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSPembrolizumabIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedDoxorubicinIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · BackgroundTestedVinblastineIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · BackgroundTestedDacarbazineIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · BackgroundTestedBrentuximab VedotinIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · BackgroundTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Pembrolizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1PembrolizumabA model not recordedTestedCurrent
Nov 1DoxorubicinA model not recordedTestedCurrent
Nov 1VinblastineA model not recordedTestedCurrent
Nov 1DacarbazineA model not recordedTestedCurrent
Nov 1Brentuximab VedotinA model not recordedTestedCurrent
Nov 18PembrolizumabRule based · role ruleTestedAgrees
Nov 18DoxorubicinRule based · role ruleBackgroundOverridden
Nov 18VinblastineRule based · role ruleBackgroundOverridden
Nov 18DacarbazineRule based · role ruleBackgroundOverridden
Nov 18Brentuximab VedotinRule based · role ruleBackgroundOverridden
As of nowHodgkin DiseaseRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.